1 asset in Hypersensitivity Reaction Disease

Therapeutic assets addressing Hypersensitivity Reaction Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Hypersensitivity Reaction Disease	Shanghai Pulmonary Hospital, Shanghai, China	P4	BBB (73)